IDiyas

For the Inventor, By the Inventor

Frankfurt am Main, Germany

Friedemann Schmidt

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:

goldMedal6 out of 1,451 
 
Sanofi
 patents

Years Active: 2015-2025

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):
1. 12275733 - Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders (2025-04-14),
2. 11827633 - Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders (2023-11-28),
3. 11130755 - Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders (2021-09-28),
4. 9718825 - N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals (2017-08-01),
5. 9221828 - N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticals (2015-12-29),
6. 9174993 - N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals (2015-11-03),

Title: Friedemann Schmidt: Innovator in Cartilage Treatment

Introduction

Friedemann Schmidt is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cartilage disorders. With a total of 6 patents to his name, Schmidt's work is recognized for its innovative approach to medical challenges.

Latest Patents

One of Schmidt's latest patents involves substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders. This invention relates to 8-aryl-substituted and 8-heteroaryl-substituted 9H-pyrido[3,4-b]indoles, which stimulate chondrogenesis and cartilage matrix synthesis. These compounds can be utilized in treating cartilage disorders and conditions requiring the regeneration of damaged cartilage, such as osteoarthritis. The patent also covers processes for synthesizing these compounds, their pharmaceutical applications, and the compositions that include them.

Career Highlights

Friedemann Schmidt is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on developing innovative solutions for complex medical issues. His contributions have been instrumental in advancing treatments that improve patient outcomes.

Collaborations

Throughout his career, Schmidt has collaborated with notable colleagues, including Marc Nazare and Nis Halland. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical solutions.

Conclusion

Friedemann Schmidt's innovative work in the field of cartilage treatment exemplifies the impact of dedicated inventors in healthcare. His patents and collaborations continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…